Ritonavir

serpin family A member 13, pseudogene ; Homo sapiens







17 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 28683645 Substitution of nevirapine or raltegravir for protease inhibitor vs. rosuvastatin treatment for the management of dyslipidaemia in HIV-infected patients on stable antiretroviral therapy (Nevrast study). 2017 Oct 2
2 26709605 Efficacy of protease inhibitor monotherapy vs. triple therapy: meta-analysis of data from 2303 patients in 13 randomized trials. 2016 May 2
3 26872331 Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens. 2016 4
4 24992294 Atazanavir exposure is effective during pregnancy regardless of tenofovir use. 2015 1
5 26196688 Factors Associated with the Development of Drug Resistance Mutations in HIV-1 Infected Children Failing Protease Inhibitor-Based Antiretroviral Therapy in South Africa. 2015 1
6 23843142 [The progression of liver fibrosis in prison inmates co-infected by HIV and HCV who started on boosted protease inhibitor therapy]. 2013 2
7 21239995 Low lopinavir plasma or hair concentrations explain second-line protease inhibitor failures in a resource-limited setting. 2011 Apr 1
8 21692667 Darunavir: an effective protease inhibitor for HIV-infected patients. 2011 Jun 1
9 21811554 Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis. 2011 1
10 18474494 Randomized study of dual versus single ritonavir-enhanced protease inhibitors for protease inhibitor-experienced patients with HIV. 2008 Mar-Apr 1
11 17594245 Cushing syndrome and severe adrenal suppression caused by fluticasone and protease inhibitor combination in an HIV-infected adolescent. 2007 Jun 1
12 15755851 Iatrogenic Cushing's syndrome with osteoporosis and secondary adrenal failure in human immunodeficiency virus-infected patients receiving inhaled corticosteroids and ritonavir-boosted protease inhibitors: six cases. 2005 Jul 2
13 15983895 Pilot study of saquinavir and lopinavir/ritonavir twice daily in protease inhibitor-naive HIV-positive patients. 2005 Mar-Apr 1
14 15090838 Resistance to amprenavir before and after treatment with lopinavir/ritonavir in highly protease inhibitor-experienced HIV patients. 2004 Jan 2 1
15 15220698 The pharmacokinetics, safety, and initial virologic response of a triple-protease inhibitor salvage regimen containing amprenavir, saquinavir, and ritonavir. 2004 Aug 1 1
16 12444942 Ritonavir plus saquinavir versus single protease inhibitor therapy in protease inhibitor-naive HIV-infected patients: the Swiss HIV Cohort Study. 2002 Oct 1
17 11134271 Human immunodeficiency virus type 1 protease cleavage site mutations associated with protease inhibitor cross-resistance selected by indinavir, ritonavir, and/or saquinavir. 2001 Jan 2